TOMS Shoes founder is pledging $100 million for psychedelic research – Here’s why he’s doing it.
Donation is believed to be ‘biggest that we’ve ever seen in the psychedelics space.’ Quest for treatments for depression, PTSD centers on MDMA, psilocybin and similar drugs.
A nascent category of mental health treatments is getting a major cash infusion. Blake Mycoskie, founder of the canvas-footwear phenomenon TOMS Shoes, has committed to giving $100 million to support …